Zobrazeno 1 - 3
of 3
pro vyhledávání: '"D. S. Zaccardelli"'
Publikováno v:
The Journal of Vascular Access. 6:177-181
Purpose Two animal studies were conducted to determine the feasibility of infusing treprostinil via a central venous catheter at an infusion rate of 0.1 mL/hour. Currently treprostinil is administered intravenously at infusion rates of approximately
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d0da8a8198f9080df4fc405e6f80b5
https://doi.org/10.1177/112972980500600404
https://doi.org/10.1177/112972980500600404
Autor:
Allison C. Widlitz, Victor F. Tapson, R.J. Barst, Abigail Krichman, Vallerie V. McLaughlin, D. S. Zaccardelli, Mardi Gomberg-Maitland, Kevin Laliberte
Publikováno v:
The journal of vascular access. 7(3)
Purpose Treprostinil is approved for the treatment of pulmonary arterial hypertension (PAH) via continuous intravenous (IV) infusion. Treprostinil's anti-platelet aggregation characteristics and stability at room temperature may allow for low infusio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f24918e68d30e61783d0047e525ed2
https://pubmed.ncbi.nlm.nih.gov/17019662
https://pubmed.ncbi.nlm.nih.gov/17019662
Autor:
A, Anzueto, R P, Baughman, K K, Guntupalli, J G, Weg, H P, Wiedemann, A A, Raventós, F, Lemaire, W, Long, D S, Zaccardelli, E N, Pattishall
Publikováno v:
The New England journal of medicine. 334(22)
Patients with acute respiratory distress syndrome (ARDS) have a deficiency of surfactant. Surfactant replacement improves physiologic function in such patients, and preliminary data suggest that it may improve survival.We conducted a prospective, mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2c14e9b776172ce527ee7d5ff148ce4
https://pubmed.ncbi.nlm.nih.gov/15329420
https://pubmed.ncbi.nlm.nih.gov/15329420